Alessandra Cesano

Dr. Alessandra Cesano is an Independent Director at Zymeworks, Inc., an Independent Non-Executive Director at Summit Therapeutics, Inc., an Independent Director at Puma Biotechnology, Inc., a Member at American Association for Cancer Research, a Member at American Society of Clinical Oncology, Inc., a Member at American Society of Hematology, a Member at European Society for Medical Oncology, a Member at International Society for Biological Therapy of Cancer, a Member at Society For Immunotherapy of Cancer and a Member at The European Hematology Association.
She is on the Board of Directors at Zymeworks, Inc., Summit Therapeutics, Inc. and Puma Biotechnology, Inc. Dr. Cesano was previously employed as a Chief Medical Officer & Executive Vice President by ESSA Pharma, Inc., a Chief Medical Officer by NanoString Technologies, Inc., a Chief Medical Officer by Cleave Biosciences, Inc., a Chief Operating & Medical Officer by Nodality, Inc., a VP & Medical Officer-Oncology Medical Research by Biogen Idec, Inc., a Vice President by Amgen, Inc., and a Principal by The Wistar Institute.
She received her undergraduate degree from Istituto Tecnico Economico O.
F.
Mossotti di Novara and a doctorate degree from the University of Turin.